Smithgall 2020 [A].
Study characteristics | |||
Patient Sampling | Two‐group study to estimate sensitivity and specificity:
‐ patients undergoing routine clinical testing by RT‐PCR (n = 113) Recruitment: unclear; describes deliberate sampling of samples with high, medium and low Ct values on the reference standard RT‐PCR Prospective or retrospective: unclear; residual swabs used but testing undertaken within 48 h of sample collection Number of samples (samples with confirmed SARS‐CoV‐2): 113 (88) |
||
Patient characteristics and setting | Setting: inpatient and ED (n from each not reported) Location: not stated; author institution is Columbia University Irving Medical Centre Country: USA Dates: 8‐13 April 2020 Symptoms and severity: not stated Demographics: 111 adult (range 23‐101 years; average 65 years for RT‐PCR‐positive and 43 years for RT‐PCR‐negative); 2 paediatric (age 1 day and 5 days) 61, 54% male Exposure history: not stated |
||
Index tests | Test name: [A] ID NOW (see Smithgall 2020 [B] for details of comparator test) (product codes not reported) Manufacturer: [A] Abbott Antigen target: [A] RdRp gene Antibody: N/A Test method: [A] isothermal PCR Samples used: residual NP swabs (collection not described) Transport media: 3 mL VTM (M4RT VTM; ThermoFisher Scientific, Waltham, MA) or UTM (UTM; Becton Dickinson and Co., Franklin Lakes, NJ) Sample storage: stored at 4 °C; testing completed within 48 h of sample collection Test operator: not stated; presume laboratory staff Definition of test positivity: automated as per manufacturer Blinding reported: not stated Timing of samples: not stated; presume on admission or presentation at ED |
||
Target condition and reference standard(s) | Reference standard: RT‐PCR with cobas SARS‐CoV‐2 assay on the 6800 platform (Roche Diagnostics, Indianapolis, IN); threshold not stated, all Ct values < 37 on both target genes Definition of non‐COVID cases: not stated; presume single RT‐PCR negative Genetic target(s): ORF1 a/b, E‐gene Samples used: as for index test Timing of reference standard: as for index test Blinded to index test: as for index test Incorporated index test: no |
||
Flow and timing | Time interval between index and reference tests: simultaneous; same samples used All participants received same reference standard: yes Missing data: none reported Uninterpretable results: Indeterminate results (index test): Xpert: 1 sample was a presumptive positive based on detection of E‐gene target but not the N2 target Indeterminate results (reference standard): none reported Unit of analysis: participants |
||
Comparative | |||
Notes | Funding: none reported Publication status: published Source: Journal of Clinical Virology Author COI: study authors report no conflicts of interest present |
||
Methodological quality | |||
Item | Authors' judgement | Risk of bias | Applicability concerns |
DOMAIN 1: Patient Selection | |||
Was a consecutive or random sample of patients enrolled? | No | ||
Was a case‐control design avoided? | No | ||
Did the study avoid inappropriate exclusions? | Unclear | ||
Did the study avoid inappropriate inclusions? | Unclear | ||
Could the selection of patients have introduced bias? | High risk | ||
Are there concerns that the included patients and setting do not match the review question? | High | ||
DOMAIN 2: Index Test (Antigen tests) | |||
DOMAIN 2: Index Test (Rapid molecular tests) | |||
Were the index test results interpreted without knowledge of the results of the reference standard? | Unclear | ||
If a threshold was used, was it pre‐specified? | No | ||
Could the conduct or interpretation of the index test have introduced bias? | High risk | ||
Are there concerns that the index test, its conduct, or interpretation differ from the review question? | High | ||
DOMAIN 3: Reference Standard | |||
Is the reference standards likely to correctly classify the target condition? | No | ||
Were the reference standard results interpreted without knowledge of the results of the index tests? | Unclear | ||
Reference standard does not incorporate result of index test? | Yes | ||
Could the reference standard, its conduct, or its interpretation have introduced bias? | High risk | ||
Are there concerns that the target condition as defined by the reference standard does not match the question? | High | ||
DOMAIN 4: Flow and Timing | |||
Was there an appropriate interval between index test and reference standard? | Yes | ||
Did all patients receive the same reference standard? | Yes | ||
Were all patients included in the analysis? | Unclear | ||
Did all participants receive a reference standard? | Yes | ||
Were results presented per patient? | Yes | ||
Could the patient flow have introduced bias? | Unclear risk |